Cardinal Health, Inc. (CAH) Earnings Call Transcripts
Cardinal Health, Inc.'s Latest Earnings Call - May 13, 2026
In the third quarter of fiscal 2026, Cardinal Health, Inc. reported strong financial results, with revenue growth driven by robust demand across its pharmaceutical and specialty businesses. The company achieved an 11% revenue increase, alongside an 18% profit growth in its pharmaceutical segment. Management raised non-GAAP EPS guidance from $10.70 to $10.80, reflecting confidence in continued operational performance and demand across its portfolio. The raised guidance and strong demand signal potential upside for the stock moving forward.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | $12.4B (beat) |
| Non-GAAP EPS | $10.80 (beat) |
| Pharmaceutical Profit Growth | 18% (positive) |
| Specialty Business Growth | >20% (positive) |
| Adjusted Free Cash Flow Guidance | $3.3B to $3.7B (beat) |
| OptiFreight Growth | strong growth (positive) |
Guidance from management
Management raised non-GAAP EPS guidance to $10.80 and expressed confidence in continued strong demand and operational performance for the remainder of fiscal 2026.
What management said
Thanks for having us Allen, and it's great to be here. Before we begin, a little housekeeping. We'll be making forward-looking statements today, which are subject to risks and uncertainties that could cause our actual results to differ materially from these projected or implied. For a description of these factors, please review our SEC filings, which can be found on our Investor Relations website at ir.cardinalhealth...
What analysts pressed on
Analysts expressed concerns regarding the impact of IRA changes and pricing pressures on future profitability. There were questions about the sustainability of growth rates in the specialty and pharmaceutical segments amid these challenges.
Main topics on the call
- Strong Demand Across Portfolio — Management highlighted 'strong demand' across all business segments, particularly in pharmaceuticals and specialty, with specialty growing over 20%. This broad-based strength is expected to continue into the next fiscal ...
- Guidance Increase — Cardinal Health raised its non-GAAP EPS guidance from '$10.70 to $10.80', indicating confidence in sustained profit growth driven by operational performance and demand.
- M&A Strategy and Integration — Management discussed ongoing integration of MSO acquisitions, specifically in gastroenterology and urology, emphasizing a strategy focused on building a strong ecosystem around these specialties.
- Impact of IRA and Pricing Trends — Despite challenges from the IRA and WAC pricing adjustments, management reported maintaining profitability, with an 18% profit growth in pharmaceuticals, indicating resilience in their business model.
Read the full Cardinal Health, Inc. transcript (May 13, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 68 calls on record spanning January 13, 2020 to May 13, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 68 Cardinal Health, Inc. earnings call transcripts on record, spanning January 13, 2020 to May 13, 2026. Based on this history, Cardinal Health, Inc. reports quarterly. The most recent call on file is dated May 13, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- CAH
- Exchange
- NYSE
- Country
- US
- Sector
- Health Care
- Calls on record
- 68
- First call
- January 13, 2020
- Most recent
- May 13, 2026
- Reporting cadence
- quarterly